UK confirms indefinite recognition of CE-marked devices

The UK Government has confirmed indefinite recognition of CE-marked medical devices, according to Med Techinsights. The decision covers medical devices and in vitro diagnostic devices in Great Britain.

Med Techinsights reports that the policy means patients across Great Britain will continue to have access to these products. The report was provided by Chris Whitehouse, a political consultant and medical technology policy and regulation expert at Whitehouse Communications, who is also a Trustee of the Bios Centre for bioethics.

What the decision covers

The confirmation concerns CE-marked products in two regulated areas: medical devices and in vitro diagnostic devices. Med Techinsights characterizes the decision as indefinite recognition by the UK Government.

For medical-device sales professionals, the update is a notable regulatory development in Great Britain because it addresses the recognition status of CE-marked products serving patients and healthcare settings.

Commercial conversations and regulatory awareness

Sales teams communicating with clinical and procurement stakeholders can monitor the government confirmation and its relevance to the CE-marked products in their portfolios. Discussions should remain aligned with the applicable product documentation, regulatory status and approved product information.

The Med Techinsights report places continued patient access at the center of the announcement. Professionals working across medical devices and diagnostics may use the update to stay current on the regulatory environment affecting Great Britain.

Source of the report

Med Techinsights published the report on the UK Government decision on October 22, 2026. The publication attributes the report to Chris Whitehouse of Whitehouse Communications and the Bios Centre for bioethics.